A bra worn during radiotherapy, and what the feasibility trial showed

External-beam radiotherapy for breast cancer is delivered in fractions, typically over days or weeks, and the technical demand is repetition. The plan is calculated once against a scan, and every subsequent session has to place the same tissue in the same place relative to the beam. Positioning lasers, skin marks and immobilisation devices all exist to serve that single requirement.

Breast tissue is not cooperative. It is mobile, its position changes with posture and breathing, and in patients with larger breasts the variation between sessions is larger. There is a second problem in the same group: the skin fold beneath the breast can receive more dose than intended, which is a common route to treatment-limiting skin reactions.

Conventional practice for these patients is to treat with the chest exposed. That solves nothing about stability and introduces a cost that does not appear in any dose calculation.

What the project set out to do

The SuPPORT 4 All project, generally shortened to S4A, was based at Sheffield Hallam University. Professor Heidi Probst and colleagues in Allied Health worked with Heath Reed of the university’s Art and Design Research Centre to design a bra that could be worn during radiotherapy rather than removed for it.

That pairing of a radiotherapy research group with a product-design centre is the notable part. The requirements pull in opposite directions. The garment has to lift and stabilise the breast, which means structure. It has to be radiolucent enough not to perturb the dose distribution, which means as little material as possible in the beam path. It has to be reproducible in fitting, because a support that sits differently each day would make the underlying problem worse rather than better. And it has to be something a patient will actually wear, daily, during a course of treatment.

The project’s stated aim was to reduce normal tissue toxicity, particularly for women with larger breasts, while preserving dignity during treatment.

What the evidence says

The garment went through a clinical feasibility trial, registered as ISRCTN38272993, and the results were reported by Probst and colleagues in Clinical Oncology in 2023.

Two findings, and the distinction between them matters:

Feasibility. The S4A bra is feasible to use in the breast cancer radiotherapy pathway. This is the primary result, and it is a statement about practicality: patients can wear it, radiographers can work with it, and it fits into an existing clinical workflow.

Dose. In women with larger breasts, the bra may reduce the mean ipsilateral lung dose — “ipsilateral” meaning the lung on the same side as the treated breast. This is reported as a possible effect in a subgroup, from a trial designed to test feasibility rather than to measure dose outcomes with statistical power.

A separate strand of the same programme looked at the patient experience of radiotherapy for breast cancer, published in 2021. That work is the reason the design brief included dignity as an explicit requirement rather than a courtesy.

What it does not establish

A feasibility trial answers “can this be done in practice”, not “does this improve outcomes”. The dose observation is a signal worth following, not a result to plan care around, and the paper frames it that way. Confirming it would need a study sized for that endpoint, and translating a lung-dose reduction into a difference in long-term toxicity would need longer follow-up again.

Nothing here is guidance for a patient. Anyone in treatment who wants to know whether a support garment is appropriate in their case has a radiographer and an oncologist who can answer against the actual plan, which is the only place that question can be answered.

Why it got attention outside the field

The coverage this project attracted, including from Sheffield Hallam’s own impact record in November 2016, tended to lead on dignity rather than dosimetry. That emphasis is understandable and slightly misleading.

The interesting engineering claim is that the two objectives are the same objective. A garment that lets a patient keep her chest covered also holds the tissue in a repeatable position. If it works, it improves the thing the physics cares about by solving the thing the patient cares about, and those are not usually the same intervention.